Screener
Emergent Biosolutions EBS All other segment — Total depreciation
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Depreciation from reportable segments: | ||||
| MCM Products | $4.3 | $4.9 | $8.8 | $9.1 |
| Items not included in depreciation from reportable segments: | ||||
| All other segment | 0.6 | 0.4 | 1.1 | 2.6 |
| Other | 1.9 | 2.0 | 3.9 | 4.7 |
| Total depreciation | $6.8 | $7.3 | $13.8 | $16.4 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Emergent Biosolutions's all other segment — total depreciation?
- Emergent Biosolutions (EBS) reported all other segment — total depreciation of $600K in Q2 2026.
- How has Emergent Biosolutions's all other segment — total depreciation changed year-over-year?
- Emergent Biosolutions's all other segment — total depreciation increased by 50.0% year-over-year, from $400K to $600K.
- What is the long-term trend for Emergent Biosolutions's all other segment — total depreciation?
- Over 2 years (2023 to 2025), Emergent Biosolutions's all other segment — total depreciation has grown at a -59.4% compound annual growth rate (CAGR), from $22.5M to $3.7M.
- What does all other segment — total depreciation mean?
- This metric represents the total depreciation expense allocated to the 'All other' business segment, which encompasses activities not captured within the primary commercial or core product segments. It reflects the systematic allocation of the cost of tangible assets used in these miscellaneous operations over their useful lives. Monitoring this figure helps investors understand the capital intensity and asset base maintenance requirements of the company's non-core business activities.
Ask your AI about Emergent Biosolutions's all other segment — total depreciation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude